Mary Thistle - Insider Trading & Ownership

Entity
Individual
Location
C/O Viacell, Inc., 245 First Street, Cambridge, MA
Summary
The estimated net worth of Mary Thistle is at least $309K dollars as of August 9, 2024. Mary Thistle is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $171K. Mary Thistle is the Director of Vigil Neuroscience, Inc. and owns shares of Vigil Neuroscience, Inc. (VIGL) stock worth about $138K.
All Insider Reports
All Insider Reports

Ownership of Mary Thistle

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
QTTB Q32 Bio Inc. Director $171K Mar 25, 2024
VIGL Vigil Neuroscience, Inc. Director $138K Jun 5, 2024
TCRT Alaunos Therapeutics, Inc. Director Jun 6, 2023
CGEM Cullinan Therapeutics, Inc. Director Aug 8, 2024
TRDA Entrada Therapeutics, Inc. Director Jun 13, 2024

Insider Transactions Reported by Mary Thistle:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.